{
  "id": 3413,
  "text": "Brachytherapy 14, 881- 888 (2015).1369.Mazeron, R., et al.Dose-volume effect relationships for late rectal morbidity in patients treated with chemoradiation and MRI-guided adaptive brachytherapy for locally advanced cervical cancer: Results from the prospective multicenter EMBRACE study.",
  "ChatGPT_query": "Please create a <question> that closely aligns with the provided <text>. Ensure that the <question> is formulated in Chinese and does not explicitly reference the text. You may incorporate specific scenarios or contexts in the <question>, allowing the <text> to serve as a comprehensive and precise answer.\n\n<text>: Brachytherapy 14, 881- 888 (2015).1369.Mazeron, R., et al.Dose-volume effect relationships for late rectal morbidity in patients treated with chemoradiation and MRI-guided adaptive brachytherapy for locally advanced cervical cancer: Results from the prospective multicenter EMBRACE study.\n\n<question>: \n\n**如果text中内容跟宫颈癌无关，请回复'SKIP'**\n",
  "ChatGPT_response_0": "在进行化疗和MRI引导的适应性近距离放射治疗期间，对于局部晚期宫颈癌患者，影响直肠晚期不良反应发生率的因素主要涉及放疗过程中剂量-体积效应关系。根据研究，直肠受到的辐射剂量及其对应的体积是关键因素之一。高剂量辐射覆盖更大体积的直肠组织往往会增加直肠晚期不良反应的风险。此外，整个治疗的综合方案，包括化疗和放疗的结合方式及其所用剂量，也对不良反应的发生率有显著影响。\n\n优化治疗方案时，精确控制直肠所受的辐射剂量和剂量体积分布是极为重要的。通过改进技术手段，如MRI引导，可以更有效地调整治疗计划，从而降低直肠晚期不良反应的发生率。随着治疗技术的进步，个体化治疗方案的设计也变得愈发重要，以最小化治疗带来的副作用。",
  "query": "在进行化疗和MRI引导的适应性近距离放射治疗期间，针对局部晚期宫颈癌患者，有哪些因素可能会影响直肠晚期不良反应的发生率？",
  "ChatGPT_query_a": "You are HuatuoGPT-II, equipped with in-depth knowledge in medicine. Your task is to directly answer the user's <question> in Chinese. In formulating your response, you must thoughtfully reference the <reference text>, ensuring that your reply does not disclose your reliance on <reference text>. Aim to provide a comprehensive and informative response, incorporating relevant insights from <reference text> to best assist the user. Please be cautious to avoid including any content that might raise ethical concerns.\n\n<question>: 在进行化疗和MRI引导的适应性近距离放射治疗期间，针对局部晚期宫颈癌患者，有哪些因素可能会影响直肠晚期不良反应的发生率？\n\n<reference text>: Brachytherapy 14, 881- 888 (2015).1369.Mazeron, R., et al.Dose-volume effect relationships for late rectal morbidity in patients treated with chemoradiation and MRI-guided adaptive brachytherapy for locally advanced cervical cancer: Results from the prospective multicenter EMBRACE study.\n\n**如果text中内容跟宫颈癌无关，请回复'SKIP'**\n\n<reply>: ",
  "response": "在进行化疗和MRI引导的适应性近距离放射治疗期间，对于局部晚期宫颈癌患者，影响直肠晚期不良反应发生率的因素主要涉及放疗过程中剂量-体积效应关系。根据研究，直肠受到的辐射剂量及其对应的体积是关键因素之一。高剂量辐射覆盖更大体积的直肠组织往往会增加直肠晚期不良反应的风险。此外，整个治疗的综合方案，包括化疗和放疗的结合方式及其所用剂量，也对不良反应的发生率有显著影响。\n\n优化治疗方案时，精确控制直肠所受的辐射剂量和剂量体积分布是极为重要的。通过改进技术手段，如MRI引导，可以更有效地调整治疗计划，从而降低直肠晚期不良反应的发生率。随着治疗技术的进步，个体化治疗方案的设计也变得愈发重要，以最小化治疗带来的副作用。"
}